Pharmacogenetic characteristics of patients with complicated phenprocoumon dosing

D. Werner (1) , U. Werner (2) , A. Wuerfel (1) , A. Grosch (3) , H. G. Lestin (3) , T. Eschenhagen (2) , T. Rau (2)

1 Department of Cardiology/Angiology
2 Institute of Clinical and Experimental Pharmacology and Toxicology
3 Institute of Laboratory Medicine

Mots clés: Anticoagulation; Coumarins; CYP2C9; CYP3A5; Pharmacogenetics; Phenprocoumon; VKORC1

D. Werner, U. Werner, A. Wuerfel, A. Grosch, H. G. Lestin, et al.. Pharmacogenetic characteristics of patients with complicated phenprocoumon dosing. European Journal of Clinical Pharmacology, 2009, 65 (8), pp.783-788. ⟨10.1007/s00228-009-0639-2⟩. ⟨hal-00534951⟩